Journal Guide

Immune System features Open Access original research and reviews reporting on translational and clinical studies encompassing all the field of immunology, bridging clinical with preclinical, and translational investigations. The journal emphasizes evidence-based clinical and laboratory research with statistically valid results that clearly help advancing our knowledge in the field. It specifically welcomes intra and inter disciplinarity Environmental immunology, Immunomics, Immunoterapy and including but not restricted to immune aspects of allergy, disorders of the respiratory tract, skin and autoimmune and neurodegenerative disorders. It encompasses original randomized controlled trials, as well as real-world evidence studies, reviews, systematic reviews, but also well-elaborated clinical cases and case-series could be acceptable. The transfer of information from fundamental research to clinical research and clinical practice is particularly welcome. Contributions and ideas from large segments of the scientific community are welcome to make Immune System a viable, much needed, and up-and-coming forum for current basic and applied immunological research.

Immunity is a monthly journal which publishes research articles and reviews of general interest in the entire discipline of immunology. Immunity was founded in the belief that advances in molecular and cellular immunology have brought immunology to a point at which a journal of high quality should be able to provide a unifying intellectual view, but the mandate for Immunity is not restricted to any particular level of analysis or to any particular type of system. The title Immunity is meant to indicate a breadth of interest extending beyond the formal definition of immunology, and into all systems that contribute to, or interact with, the immune system of the organism. Submitted articles are reviewed for both technical excellence and general interest, and those that are accepted are published within ten weeks.Immunity follows the example ofCell in defining criteria for general interest that are just as important as technical quality in deciding on the acceptability of submissions. The area of interest is defined broadly beyond the obvious characterization of immune genes and cells, effectively including any and all research that contributes to understanding of infection and host defenses. Practical consequences for clinical work are taken into account equally with advances in fundamental understanding.Visit the Immunity website to find out more - http://www.immunity.com .

The Indian Association of Dermatologists, Venereologists & Leprologists (IADVL) is the national association of Indian medical specialists who manage patients with skin disorders, sexually transmitted infections (STIs) or leprosy. The current member strength of the association is more than 6000. The association works for the betterment of the specialty by holding academic meetings, printing a journal and publishing a textbook. The IADVL has several state branches, each with their own office bearers, which function independently within the constitution of the IADVL.

The journal accepts original research articles, viewpoints, review articles, success stories, interesting case series and case reports on patients suffering from pulmonary, extra-pulmonary tuberculosis as well as other respiratory diseases, Radiology Forum, Short Communications, Book Reviews, abstracts, letters to the editor, editorials on topics of current interest etc.

The articles published in IJTB are a key source of information on research in tuberculosis. The journal is indexed in Medline

The journal Infection is a peer-reviewed forum for the presentation and discussion of clinically relevant information on infectious diseases for readers and contributors from all over the world. Articles deal with etiology, pathogenesis, diagnosis and treatment of infectious diseases in outpatient and inpatient setting. Public health issues of local, regional and international importance related to infectious diseases are covered along with progress and problems in hospital epidemiology. The main contents include original articles describing results of research projects; brief reports on new observations that enhance the knowledge of clinicians; and state-of-the-art reviews on topics relevant to physicians diagnosing or treating infectious diseases. Case reports describing new infectious etiologies or clinical manifestations are also offered. Infection adheres to a high standard of quality of all published material.

This is a Subscribe to Open journal. The below estimate Article Processing Charges (APCs) are $0.00 but additional page charges will apply. More information here.

Infection and Immunity® publishes research related to infections caused by pathogenic bacteria, fungi, and parasites; molecular mechanisms of pathogenicity; interactions of virulence factors with host cells; innate and adaptive immunity to infection; development of vaccines against nonviral pathogens; and genomes of pathogenic bacteria. IAI also welcomes studies on the interaction of microbial communities with their host.

Infectious diseases constitute one of the main challenges to medical science in the coming century. The impressive development of molecular megatechnologies and of bioinformatics have greatly increased our knowledge of the evolution, transmission and pathogenicity of infectious diseases. Research has shown that host susceptibility to many infectious diseases has a genetic basis. Furthermore, much is now known on the molecular epidemiology, evolution and virulence of pathogenic agents, as well as their resistance to drugs, vaccines, and antibiotics. Equally, research on the genetics of disease vectors has greatly improved our understanding of their systematics, has increased our capacity to identify target populations for control or intervention, and has provided detailed information on the mechanisms of insecticide resistance.However, the genetics and evolutionary biology of hosts, pathogens and vectors have tended to develop as three separate fields of research. This artificial compartmentalisation is of concern due to our growing appreciation of the strong coevolutionary interactions among hosts, pathogens and vectors.Infection, Genetics and Evolution and its companion congress MEEGID (for Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases) are the main forum acting for the cross-fertilization between evolutionary science and biomedical research on infectious diseases.Infection, Genetics and Evolution is the only journal that welcomes articles dealing with the genetics and evolutionary biology of hosts, pathogens and vectors, and coevolution processes among them in relation to infection and disease manifestation. All infectious models enter the scope of the journal, including pathogens of humans, animals and plants, either parasites, fungi, bacteria, viruses or prions. The journal welcomes articles dealing with genetics, population genetics, genomics, postgenomics, gene expression, evolutionary biology, population dynamics, mathematical modeling and bioinformatics.We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Infectious Agents and Cancer is ready to receive manuscripts on all aspects of the pathogenic mechanisms of chronic infections and progression to oncogenesis.

Infectious Disease Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, rrinary tract infections, and viral infections.Infectious Disease Clinics of North America is published four times each year, March, June, September, and December.

Infectious Disease Modelling is a peer-reviewed open access journal aiming to promote research working to interface mathematical modelling, infection disease data retrieval and analysis, and public health decision support. The journal welcomes original research contributing to the enhancement of this interface, and review articles of cutting edge methodologies motivated by and applicable to data collection and informatics for public health decision making and policy.

L'organe d'expression de la Société de Pathologie Infectieuse de Langue Française (SPILF).Médecine et maladies infectieuses est indexée dans les principales bases de données internationales. Elle publie des articles scientifiques en anglais et en français, articles originaux, revues générales, communications brèves et lettres à la rédaction, qui abordent les différentes pathologies infectieuses et leurs agents pathogènes. Les axes d'étude de la revue concernent autant la clinique, la prévention, la biologie, les infections nosocomiales que l'épidémiologie et la thérapeutique.

Una publicación idónea para mantenerse al día sobre nuevos agentes patógenos, cepas resistentes... mediante los últimos trabajos de investigación clínicos y microbiológicos. Además es la Publicación Oficial de la SEIMC y posee un alto factor de impacto entre los profesionales.10 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/eimc

Infectious Diseases and Therapy is an open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on high quality pre-clinical, clinical (phases 1-4), and real world research around the discovery,  development, and use of infectious disease therapies. The journal also encourages diagnostic,  pharmacoeconomic, public health, educational, and quality of life studies as well as research around the prevention and management of infectious disease. Areas of focus include, but are not limited to, chronic infections, vaccines, drug-resistant pathogens, microbiology, epidemiology, and tropical, emergent, and sexually-transmitted diseases.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Infectious Diseases and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to clare.shepherd@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer., Your article will be immediately and permanently available with open access.